31 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
as the probability-weighted present value of the expected benefit of the investment.
The Company used the Black-Scholes option-pricing model, which … of the 2017 Series A Investor Call Option valued using the Black- Scholes option pricing model:
August 2017
Second Tranche Closing
Series A Convertible
10-K
2017 FY
RYTM
Rhythm Pharmaceuticals Inc.
12 Mar 18
Annual report
12:00am
of the Series A Investor Right/Obligations as the probability‑weighted present value of the expected benefit of the investment.
We used the Black … using the Black-Scholes option-pricing model, which requires the input of highly subjective assumptions, including (a) the expected volatility of our
DEF 14A
m91xfth5 bsq
30 Apr 18
Definitive proxy
4:01pm
10-Q
h5i4p5m
14 Nov 17
Quarterly report
12:00am
424B5
u49dlz8flvd
15 Oct 19
Prospectus supplement for primary offering
4:51pm